Validation of LC-MS/MS method for the quantification of risperidone and its active metabolite 9-OH-risperidone in human plasma and its application in a bioequivalence study (2010)
- Authors:
- Autor USP: GATTAZ, WAGNER FARID - FM
- Unidade: FM
- Subjects: BIOEQUIVALÊNCIA; FARMACOCINÉTICA CLÍNICA; VALIDAÇÃO DE MODELOS; PLASMA (ANÁLISE QUANTITATIVA); RESUMOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 46, suppl. 2, p. 11 res. FCF018, 2010
- Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo
-
ABNT
BELOTTO, Karisa Cristina Rodrigues et al. Validation of LC-MS/MS method for the quantification of risperidone and its active metabolite 9-OH-risperidone in human plasma and its application in a bioequivalence study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 12 fev. 2026. , 2010 -
APA
Belotto, K. C. R., Raposo, N. R. B., Ferreira, A. S., & Gattaz, W. F. (2010). Validation of LC-MS/MS method for the quantification of risperidone and its active metabolite 9-OH-risperidone in human plasma and its application in a bioequivalence study. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Belotto KCR, Raposo NRB, Ferreira AS, Gattaz WF. Validation of LC-MS/MS method for the quantification of risperidone and its active metabolite 9-OH-risperidone in human plasma and its application in a bioequivalence study. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 11 res. FCF018.[citado 2026 fev. 12 ] -
Vancouver
Belotto KCR, Raposo NRB, Ferreira AS, Gattaz WF. Validation of LC-MS/MS method for the quantification of risperidone and its active metabolite 9-OH-risperidone in human plasma and its application in a bioequivalence study. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 11 res. FCF018.[citado 2026 fev. 12 ] - Atividade de subtipos de 'PLA IND. 2' em neurônios primários mantidos em cultura
- Inibição da fosfolipase 'A IND. 2' e hiperfosforilação da proteína Tau em culturas primárias de neurônios corticais e hipocampais
- GSK3beta em plaquetas de indivíduos com doença de Alzheimer e comprometimento cognitivo leve
- Lítio inibe a transcrição de GSK3b: implicações para a doença de Alzheimer
- Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder
- Increased phospholipase A2 activity in schizophrenia with absent response to niacin
- Hippocampal serotonin depletion is related to the presence of generalized tonic-clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy
- Detecção da translocação T (11;18) AP12/MALTI associada a linfoma malt gástrico em especimens de biópsia pelas técnicas de RT-PCR e FISH
- CYP2C9 Intermediate and Poor Metabolizers are More Prevalent in a Sample of Refractory Mood Disorders Patients Undergoing ECT
- Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
